Related Experiment Video
Updated: Mar 12, 2026

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
Cardioacrofacial dysplasia 1: a case report and literature review
Chen Liang1, Zhihua Wang2, Gaigai Bai2
1Department of Second Orthopedics, Xi'an Central Hospital, Xi'an, China.
Insights
Cardioacrofacial dysplasia 1 (CAFD1) is a rare skeletal ciliopathy. A new case report details a patient with a PRKACA gene mutation, expanding knowledge of this condition and its treatment.
Area of Science:
- Genetics
- Molecular Biology
- Pediatrics
Background:
- Cardioacrofacial dysplasia 1 (CAFD1) is a rare skeletal ciliopathy.
- It is caused by pathogenic variants in the PRKACA gene.
- CAFD1 shares phenotypic overlap with Ellis-van Creveld (EvC) syndrome, with only five cases previously reported worldwide, all with the p.Gly137Arg mutation.
Background:
Cardioacrofacial dysplasia 1 [CAFD1; Online Mendelian Inheritance in Man (OMIM): #619142] is a rare skeletal ciliopathy caused by pathogenic variants in the PRKACA gene, exhibiting phenotypic overlap with conditions such as Ellis-van Creveld (EvC) syndrome. To date, only five cases have been reported worldwide, all carrying the identical p. Gly137Arg mutation.
Case Description:
A 10-year-old male patient presented with short stature, progressive bilateral knee deformities, post-axial posterior polydactyly, and hypoplasia of teeth and nails since infancy. He had a history of partial atrial septal defect, functional single atrium, and pulmonary valve stenosis, undergoing cardiac repair at age 5 and bilateral polydactyly resection at age 7. Whole-exome sequencing (WES) confirmed a de novo heterozygous mutation in the PRKACA gene: c.409G>A (p.Gly137Arg). At age 10, the patient underwent robot-assisted bilateral proximal tibial epiphyseal fixation. One-month postoperative follow-up demonstrated significant improvement in gait and mobility.
Conclusions:
To our knowledge, this expands the known geographic distribution with PRKACA c.409G>A (p.Gly137Arg). The finding adds to prior reports that repeatedly implicate this variant; broader ascertainment is needed to establish whether it represents a true hotspot. In patients with an EvC-like phenotype who test negative for EVC/EVC2, screening of PRKACA can be considered. Prior work suggests that increased protein kinase A (PKA) catalytic activity may dampen Hedgehog (Hh) signaling, providing a plausible mechanism for the skeletal and cardiac findings. Early molecular diagnosis facilitates multidisciplinary management and genetic counseling.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiovascular System Abnormal Findings I: Inspection and Palpation
Abnormal findings observed during an inspection
